In Harrington v. Purdue Pharma L.P., will the Supreme Court rule that a bankruptcy court could approve OxyContin-maker Purdue Pharma's reorganization plan, which includes nonconsensual, nondebtor releases?

Started Oct 06, 2023 05:00PM UTC
Closed Jun 27, 2024 02:10PM UTC
Challenges
Tags

Purdue Pharma declared bankruptcy as it faced heavy liability for its role in the US opioid crisis, and agreed in a bankruptcy court to contribute billions of dollars in exchange for, among other things, a release from further civil liability for the Sackler family owners of the firm (AP, CNN, USA Today). A federal district court ruled that the bankruptcy court lacked the authority to approve a plan that included nonconsensual releases for third parties, which the Second Circuit reversed due to binding precedent (Oyez, SCOTUSblog, Second Circuit - In Re: Purdue Pharma (2023)). The Supreme Court is expected to hand down its decision in its 2023 term, but if it does not, the question will close as "No." If the Court decides this case without addressing this question's particular issue of law, the question will close as "No."

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.


The question closed "No" with a closing date of 27 June 2024.

See our FAQ to learn about how we resolve questions and how scores are calculated.

Possible Answer Correct? Final Crowd Forecast
Yes 68%
No 32%

Crowd Forecast Profile

Participation Level
Number of Forecasters 27
Average for questions older than 6 months: 190
Number of Forecasts 68
Average for questions older than 6 months: 548
Accuracy
Participants in this question vs. all forecasters average

Most Accurate

Relative Brier Score

1.
-0.579027
2.
-0.451663
3.
-0.273829
4.
-0.200762
5.
-0.197396

Recent Consensus, Probability Over Time

Files
Tip: Mention someone by typing @username